Usefulness of a novel system for measuring glucose area under the curve while screening for glucose intolerance in outpatients

Aims/Introduction To realize the effectiveness of a novel system for measuring glucose area under the curve ( AUC ) using minimally invasive interstitial fluid extraction technology ( MIET ), outpatients undergoing oral glucose tolerance tests ( OGTT ) were investigated for the efficacy of screening for glucose intolerance using this system. Materials and Methods Fifty outpatients scheduled to undergo a 75‐g OGTT for medical reasons were recruited to the study. An area of skin on the forearm was pretreated with microneedle arrays before the application of hydrogels for interstitial fluid extraction. Plasma glucose ( PG ) levels were measured every 30 min for 2 h to calculate reference (actual) AUC . The AUC was predicted by MIET on the basis of glucose extracted by the hydrogel using sodium ion levels as the internal standard. Results Good correlation between MIET ‐predicted and reference AUC s obtained using PG levels was confirmed for a wide AUC range. By introducing a threshold level for AUC to separate glucose intolerance with peak glucose ≥180 mg/dL from normal glucose tolerance, the system was demonstrated to provide better screening accuracy compared with conventional methods that use H b A 1c and fasting PG levels. The results of a questionnaire‐based survey administered to the subjects suggested that this system was readily accepted by the majority as a painless monitoring method. Conclusions The findings suggest that our glucose AUC measurement system using MIET would be useful for screening of glucose intolerance. In the future, this system may prove to be a useful aid as a screen for glucose intolerance before performing an OGTT for diagnosis.